Meningococcal Vaccination

Pronounced (muh-nin-jo-cok-ul)

Meningococcal vaccines are now available that help protect against all three serogroups of meningococcal disease that are most commonly seen in the United States (serogroups B, C and Y), but they will not prevent all cases. There are three kinds of meningococcal vaccines available in the United States:

Meningococcal conjugate vaccines (Menactra®, MenHibrix® and Menveo®)
Meningococcal polysaccharide vaccine (Menomune®)
Serogroup B meningococcal vaccines (Bexsero® and Trumenba®)

View the table below to learn which meningococcal serogroups are covered by each vaccine.

Trade name	Type of Vaccine	Meningococcal Serogroups Covered
Bexsero®	Recombinant	B
Menactra®	Conjugate	A, C, W, Y
MenHibrix®	Conjugate	C, Y (and Haemophilus influenzae type b [Hib])
Menomune®	Polysaccharide	A, C, W, Y
Menveo®	Conjugate	A, C, W, Y
Trumenba®	Recombinant	B

What Everyone Should Know
Basic information for people interested in the vaccine
Information for Healthcare Professionals
Vaccine recommendations and contraindications; composition, dosage, and administration; handling and storage

Related Pages

Syndicated Content Details:
Source URL: http://www.cdc.gov/vaccines/vpd-vac/mening/default.htm
Source Agency: Centers for Disease Control and Prevention (CDC)
Captured Date: 2016-05-23 23:12:56.0